The attbf chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the attbf chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The attbf stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View attbf Detailed Price Forecast - CNN Money||View attbf Detailed Summary - Google Finance|
|View attbf Detailed Summary - Yahoo! Finance||View attbf Stock Research & Analysis - Zacks.com|
|View attbf Trends & Analysis - Trade-Ideas||View attbf Major Holders - Barrons|
|View attbf Call Transcripts - NASDAQ||View attbf Breaking News & Analysis - Seeking Alpha|
|View attbf Annual Report - CompanySpotlight.com||View attbf OTC Short Report - OTCShortReport.com|
|View attbf Fundamentals - TradeKing||View attbf SEC Filings - Bar Chart|
|View Historical Prices for attbf - The WSJ||View Performance/Total Return for attbf - Morningstar|
|View the Analyst Estimates for attbf - MarketWatch||View the Earnings History for attbf - CNBC|
|View the attbf Earnings - StockMarketWatch||View attbf Buy or Sell Recommendations - MacroAxis|
|View the attbf Bullish Patterns - American Bulls||View attbf Short Pain Metrics - ShortPainBot.com|
|View attbf Stock Mentions - StockTwits||View attbf Stock Mentions - PennyStockTweets|
|View attbf Stock Mentions - Twitter||View attbf Investment Forum News - Investor Hub|
|View attbf Stock Mentions - Yahoo! Message Board||View attbf Stock Mentions - Seeking Alpha|
|View Insider Transactions for attbf - SECform4.com||View Insider Transactions for attbf - Insider Cow|
|View attbf Major Holdings Summary - CNBC||View Insider Disclosure for attbf - OTC Markets|
|View Insider Transactions for attbf - Yahoo! Finance||View Institutional Holdings for attbf - NASDAQ|
|View attbf Stock Insight & Charts - FinViz.com||View attbf Investment Charts - StockCharts.com|
|View attbf Stock Overview & Charts - BarChart||View attbf User Generated Charts - Trading View|
Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
Posted on Tuesday April 02, 2019
VANCOUVER, British Columbia, April 2, 2019 /PRNewswire/ -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (ATT.CN) (ATTBF) is pleased to announce that its wholly-owned subsidiary, 1185277 B.C. Ltd. (the "Acquisition Subsidiary"), has entered into a share purchase agreement (the "Agreement") to acquire (the "Acquisition") Pro Natura BV ("Pro Natura"), a privately held nutraceutical company based in Oisterwijk, Netherlands. Pro Natura has over 30 years of operations and sales experience in Europe, with over 100 products that have been marketed to both long-term repeat customers and new large groups of distributors. Pro Natura has been supported by a seasoned management team that still includes its original founder and has historically boasted €10M+ in per annum sales.
Abattis Announces Resignation of Directors
Posted on Saturday March 09, 2019
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - Abattis Bioceuticals Corp (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James Irving have respectively resigned as directors of the Company.The Company thanks both Mr. Richter and Mr. Irving for their service and wishes each all the best in their future endeavors.About Abattis Bioceuticals Corp.Abattis is positioned to be ...
Abattis Provides Update on Conference Call
Posted on Wednesday February 27, 2019
Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) provides the following update on the Company’s recent trading halt and upcoming conference call with Company management that was previously set for March 1, 2019. Further to the Company’s news release dated February 18, 2019, trading of the Company’s common shares continues to be halted on the Canadian Securities Exchange until the Company files its financial statements for the year ended September 30, 2018 (the “Financials”).
Abattis Provides Update on Trading Halt and Announces Management Conference Call
Posted on Monday February 18, 2019
Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide the following update on the Company’s recent trading halt and upcoming conference call with Company management set for March 1, 2019. On February 4, 2019, the trading of the Company’s common shares was halted due to the Company’s failure to file its year-end financial statements within the 90 day filing deadline required under National Instrument 51-102 – Continuous Disclosure Requirements. The Company is still undergoing its year-end financial statement audit and believes it will have them filed in the coming week.